During the past decade, Women's Care Center, PLC Research Memphis Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Women's Care Center, PLC Research Memphis Associates" are "Uterine Fibroids" (2 trials). Many other conditions were trialed in "Women's Care Center, PLC Research Memphis Associates" in a lesser frequency.

Most popular intervention types in "Women's Care Center, PLC Research Memphis Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Proellex" (1 trials), "Proellex 25 mg" (1 trials) and "Proellex 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Women's Care Center, PLC Research Memphis Associates" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Women's Care Center, PLC Research Memphis Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Women's Care Center, PLC Research Memphis Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Women's Care Center, PLC Research Memphis Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".